Adverse drug event detection in Latvian administrative data
Health risks of medicines in clinical practice often differ from trial data, making adverse drug event (ADE) monitoring essential for post-marketing surveillance. In Latvia, ADE reporting is available but remains low, indicating substantial underreporting. This study aimed to identify unreported ADE cases in administra...